Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.
Featured Content
New Content |view more
The fellows are treating complex conditions in the large population that the Mount Sinai Health System serves, and working closely with renowned experts in the field.
Findings could improve long-term outcomes for patients
Endocrinology, Diabetes and Bone Disease 2025
The Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai is dedicated to advancing the understanding and treatment of diabetes, obesity, conditions affecting ...
The faculty in the Division of Endocrinology, Diabetes and Bone Disease continue to drive advances in translational research and clinical care.
Mount Sinai Lab Paves the Way for a New Era of Therapeutic Solutions for Thyroid Disease
With the publication of two 2024 studies, the Mount Sinai team led by Terry F. Davies, MD, continued to expand understanding of the physiologic mechanisms of Graves’ disease, as well as of thyroid eye disease, which about a third of people ...
Studies on Transgender Hormone Therapy Provide New Insights for Endocrinologists
Two 2024 studies from Mount Sinai—one on the risk of venous thromboembolism in transgender people and the other on understanding the effects of estrogen dose and route of administration on serum levels—provide vital information and insights ...
Review Highlights Endocrinologists’ Crucial Role in Diagnosing and Treating Adrenocortical Carcinoma
A case review by a team at the Icahn School of Medicine at Mount Sinai highlighted the crucial role of endocrinologists in the assessment and management of patients with adrenocortical carcinoma, a rare and aggressive form of cancer.
With Expanded Research, Mount Sinai Teams Aim to Support More Patients With Diabetes Technology
Carol J. Levy, MD, and teams at the Mount Sinai Diabetes Center are working to broaden the reach of diabetes technology to more people who could benefit from it, including pregnant women with type 1 diabetes and people with type 2 diabetes ...
While much is known about how organs such as the liver, fat tissue, and pancreas contribute to metabolic diseases, a Mount Sinai researcher and his team have turned their focus to a novel subject—the mammary gland.
Initiative Calls for Updated Standards in Testing for Suspected Low Testosterone
Inaccuracies in laboratory testosterone testing have long hindered appropriate management in several patient groups, including women with polycystic ovary syndrome and men with suspected low testosterone.
Diabetes, Obesity and Metabolism Institute Advances Understanding of Beta Cells and More
The Institute made further outstanding progress in the study of diabetes, obesity, and metabolic syndromes under the leadership of the Institute Director, Andrew F. Stewart, MD.
Mount Sinai researchers examined the significance of prediabetes prior to conception among adolescents and young adults, a group that is most at risk of unplanned pregnancy. The findings could alter how doctors routinely screen or counsel ...